These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30664347)

  • 1. Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods.
    Dvorakova M; Kejlová K; Rucki M; Jírová D
    Neuro Endocrinol Lett; 2018 Dec; 39(5):409-416. PubMed ID: 30664347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative methods in vitro for screening of endocrine disruptors.
    Dvořáková M; Kejlová K; Bendová H; Rucki M; Kohout P; Vavrouš A; Jírová D
    Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):123-131. PubMed ID: 28263540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS).
    Mertl J; Kirchnawy C; Osorio V; Grininger A; Richter A; Bergmair J; Pyerin M; Washüttl M; Tacker M
    PLoS One; 2014; 9(7):e100952. PubMed ID: 25000404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
    Conroy-Ben O; Garcia I; Teske SS
    Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Mono-(2-Ethylhexyl) Phthalate (MEHP) on Human Estrogen Receptor (hER) and Androgen Receptor (hAR) by YES/YAS In Vitro Assay.
    Kim DH; Park CG; Kim SH; Kim YJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling the H295R with ERα and AR U2OS CALUX assays enables simultaneous testing for estrogenic, anti-androgenic and steroidogenic modalities.
    Nikopaschou MS; Félix A; Mollergues J; Scholz G; Schilter B; Marin-Kuan M; Fussell KC
    Toxicol Sci; 2023 Jul; 194(2):191-208. PubMed ID: 37261848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.
    Liu X; Sakai H; Nishigori M; Suyama K; Nawaji T; Ikeda S; Nishigouchi M; Okada H; Matsushima A; Nose T; Shimohigashi M; Shimohigashi Y
    Toxicol Appl Pharmacol; 2019 Aug; 377():114610. PubMed ID: 31195007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials.
    Chen Q; Zhou C; Shi W; Wang X; Xia P; Song M; Liu J; Zhu H; Zhang X; Wei S; Yu H
    Sci Total Environ; 2020 Aug; 728():138854. PubMed ID: 32570315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of vinclozolin metabolites with human estrogen receptors 1GWR-α and 1QKM and androgen receptor 2AM9-β: Implication for endocrine disruption.
    Habib H; Haider MR; Sharma S; Ahmad S; Dabeer S; Yar MS; Raisuddin S
    Toxicol Mech Methods; 2020 Jun; 30(5):370-377. PubMed ID: 32208804
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine Disruptors Acting on Estrogen and Androgen Pathways Cause Reproductive Disorders through Multiple Mechanisms: A Review.
    Amir S; Shah STA; Mamoulakis C; Docea AO; Kalantzi OI; Zachariou A; Calina D; Carvalho F; Sofikitis N; Makrigiannakis A; Tsatsakis A
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33557243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic depsipeptide mycotoxin exposure may cause human endocrine disruption: Evidence from OECD in vitro stably transfected transcriptional activation assays.
    Park Y; Lee HS
    Reprod Toxicol; 2021 Mar; 100():52-59. PubMed ID: 33346041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying potential endocrine disruptors among industrial chemicals and their metabolites--development and evaluation of in silico tools.
    Rybacka A; Rudén C; Tetko IV; Andersson PL
    Chemosphere; 2015 Nov; 139():372-8. PubMed ID: 26210185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
    Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
    Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.
    Ng HW; Zhang W; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S4. PubMed ID: 25349983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
    Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
    Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
    Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
    Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of In Vitro Endocrine Activities of
    Mallia V; Ivanova L; Eriksen GS; Harper E; Connolly L; Uhlig S
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential endocrine disruption mechanism of anthelmintic drug niclosamide by activating estrogen receptors and estrogen-related receptors.
    He S; Li X; Ma JZ; Yang Y; Luo S; Xie XD; Yan BH; Yang J; Luo L; Cao LY
    Toxicology; 2021 Jun; 457():152805. PubMed ID: 33961950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.